CSB 2.012 Note(3) Paragraph (km) of s. 161.20 (2), Stats., is renumbered to read:
CSB 2.012 Note(mg) Prazepam;
CSB 2.012 Note(4) Paragraph (hg) of s. 161.20 (2), Stats., is created to read: CSB 2.012 Note(hg) Midazolam;
CSB 2.012 Note(5) Paragraph (mm) of s. 161.20 (2), Stats., is created to read: CSB 2.012 Note(mm) Quazepam;
CSB 2.012 Note(6) Paragraph (km) of s. 161.18 (3), Stats., is created to read: CSB 2.012 Note(km) Tiletamine and Zolazepam or any salt thereof;
CSB 2.012 Note(7) Paragraph (a) of s. 161.16 (3), Stats., is renumbered to read:
CSB 2.012 Note(am) Alphaprodine;
CSB 2.012 Note(8) Paragraph (a) of s. 161.16 (3), Stats., is created to read: CSB 2.012 Note(a) Alfentanil;
CSB 2.012 Note(9) Paragraph (rg) of s. 161.14 (2), Stats., is created to read: CSB 2.012 Note(rg) MPPP 1-methyl-4-phenyl-4-propionoxypiperidine);
CSB 2.012 Note(10) Paragraph (vg) of s. 161.14 (2), Stats., is created to read: CSB 2.012 Note(vg) (PEPAP) 1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine;
CSB 2.012 Note(11) Paragraph (b) of s. 161.16 (10), Stats., is created to read: CSB 2.012 Note(b) Nabilone (another name for nabilone: (+)-trans-3- (1,1-dimethylheptyl)-6, 6a, 7, 8, 10, 10a-hexahydro-1- hydroxy-6, 6-dimethyl-9H-dibenzo [b,d] pyran-9-one).
CSB 2.012 Note(12) Subsection (2) of s. 161.14, Stats., is amended to read: CSB 2.012 Note(2) Opiates. Unless specifically excepted under federal regulations or unless listed in another schedule, any of the following opiates, or their isomers, esters, ethers, salts, salts of isomers, esters of ethers, if isomers, esters, ethers, salts or salts of isomers exist within the specified chemical designation (for purposes of par. (tg) only, the term isomer includes the optical and geometric isomers):
CSB 2.012 Note(13) Paragraph (a) of s. 161.14 (2), Stats., is renumbered to read:
CSB 2.012 Note(ag) Acetylmethadol;
CSB 2.012 Note(14) Paragraph (a) of s. 161.14 (2), Stats., is created to read: CSB 2.012 Note(a) Acetyl-alpha-methylfentanyl (N-(1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide);
CSB 2.012 Note(15) Paragraph (cg) of s. 161.14 (2), Stats., is created to read: CSB 2.012 Note(cg) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);
CSB 2.012 Note(16) Paragraph (dg) of s. 161.14 (2), Stats., is created to read: CSB 2.012 Note(dg) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl) -4-piperidinyl]-N-phenylpropanamide);
CSB 2.012 Note(17) Paragraph (rj) of s. 161.14 (2), Stats., is created to read: CSB 2.012 Note(rj) 3-methylthiofentanyl (N-[3-methyl-1-(2-thienyl) ethyl-4-piperidinyl]-N-phenylpropanamide);
CSB 2.012 Note(18) Paragraph (tg) of s. 161.14 (2), Stats., is created to read: CSB 2.012 Note(tg) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1- (2-phenethyl)-4-piperidinyl]propanamide);
CSB 2.012 Note(19) Paragraph (xm) of s. 161.14 (2), Stats., is created to read: CSB 2.012 Note(xm) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]propanamide);
CSB 2.012 HistoryHistory: Cr. Register, February, 1988, No. 386, eff. 3-1-88. CSB 2.012 NoteCSB 2.20 Addition of beta-hydroxy-3-methylfentanyl to schedule I. Paragraph (er) of s. 161.14 (2), Stats., is created to read: CSB 2.012 Note(er) Beta-hydroxy-3-methylfentanyl.
CSB 2.012 HistoryHistory: Cr. Register, July, 1989, No. 403, eff. 8-1-89. CSB 2.012 NoteCSB 2.21 Additions, deletions, corrections, transfers, and amendments to drug schedules. (1) Subsection (1) of s. 161.14, Stats., is amended to read: CSB 2.012 Note(1) Included substances. Unless specifically excepted by state or federal law or regulation or more specifically included in another schedule, the following controlled substances are listed in schedule I.
CSB 2.012 Note(2) Paragraph (a) of s. 161.14 (2), Stats., is amended to read: CSB 2.012 Note(a) Acetyl-alpha-methylfentany (N-[1-(1-methyl-2-phenylethyl)-4-piperidinyl]-N-phenylacetamide);
CSB 2.012 Note(3) Paragraph (er) of s. 161.14 (2), Stats., is amended to read: CSB 2.012 Note(er) Beta-hydroxy-3-methylfentanyl (N-[1-(2-hydroxy-2- phenylethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide);
CSB 2.012 Note(4) Paragraph (rg) of s. 161.14 (2), Stats., is amended to read: CSB 2.012 Note(rg) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);
CSB 2.012 Note(5) Paragraph (qs) of s. 161.14 (2), Stats., is amended to read: CSB 2.012 Note(qs) 3-methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-
piperidinyl]-N-phenylpropanamide);
CSB 2.012 Note(6) Paragraph (tg) of s. 161.14 (2), Stats., is amended to read: CSB 2.012 Note(tg) Para-fluorofentanyl (N-[1-(2-phenylethyl)-4-piperidinyl]-N-(4-fluorophenyl)propanamide);
CSB 2.012 Note(7) Paragraph (vg) of s. 161.14 (2), Stats., is amended to read: CSB 2.012 Note(vg) PEPAP (1-(2-phenylethyl)-4-phenyl-4-acetoxypiperidine);
CSB 2.012 Note(8) Paragraph (xm) of s. 161.14 (2), Stats., is amended to read: CSB 2.012 Note(xm) Thiofentanyl (N-[1-(2-thienyl)ethyl-4-piperidinyl]-N-
phenylpropanamide);
CSB 2.012 Note(9) Paragraph (cd) of s. 161.14 (2), Stats., is created to read: CSB 2.012 Note(cd) Alpha-methylfentanyl (N-[1-(1-methyl-2-phenylethyl)-4-piperidinyl]-N-phenylpropanamide);
CSB 2.012 Note(10) Paragraph (e) of s. 161.14 (3), Stats., is amended to read: CSB 2.012 Note(e) Codeine-N-oxide;
CSB 2.012 Note(11) Paragraph (j) of s. 161.14 (3), Stats., is amended to read: CSB 2.012 Note(j) Etorphine, except its hydrochloride salts;
CSB 2.012 Note(12) Paragraph (s) of s. 161.14 (3), Stats., is amended to read: CSB 2.012 Note(s) Morphine-N-oxide;
CSB 2.012 Note(13) Paragraph (a) of s. 161.14 (4), Stats., is amended to read: CSB 2.012 Note(a) 3,4-methylenedioxyamphetamine, commonly known as “MDA”;
CSB 2.012 Note(14) Paragraph (b) of s. 161.14 (4), Stats., is amended to read: CSB 2.012 Note(b) 5-methoxy-3,4-methylenedioxyamphetamine;
CSB 2.012 Note(15) Paragraph (c) of s. 161.14 (4), Stats., is amended to read: CSB 2.012 Note(c) 3,4,5-trimethoxyamphetamine;
CSB 2.012 Note(16) Paragraph (ag) of s. 161.14 (4), Stats., is created to read: CSB 2.012 Note(ag) 3,4-methylenedioxyethylamphetamine, commonly known as “MDE”;
CSB 2.012 Note(17) Paragraph (ar) of s. 161.14 (4), Stats., is created to read: CSB 2.012 Note(ar) N-hydroxy-3,4-methylenedioxyamphetamine;
CSB 2.012 Note(18) Paragraph (u) of s. 161.14 (4), Stats., is amended to read: CSB 2.012 Note(u) 1-[1-(2-thienyl)cyclohexyl]piperidine, which is the thiophene analog of phencyclidine;
CSB 2.012 Note(19) Paragraph (ud) of s. 161.14 (4), Stats., is created to read: CSB 2.012 Note(ud) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine, which is the thiophene pyrrolidine analog of phencyclidine;
CSB 2.012 Note(20) Paragraph (ur) of s. 161.14 (4), Stats., is amended to read: CSB 2.012 Note(ur) 1-(1-phenylcyclohexyl)pyrrolidine, which is the pyrrolidine analog of phencyclidine;
CSB 2.012 Note(21) Paragraph (d) of s. 161.14 (7), Stats., is created to read: CSB 2.012 Note(d) 4-methylaminorex, including its salts and salts of isomers;
CSB 2.012 Note(22) Paragraph (e) of s. 161.14 (7), Stats., is created to read: CSB 2.012 Note(e) N,N-dimethylamphetamine, including its salts and salts of isomers.
CSB 2.012 Note(23) Paragraph (L) of s. 161.14 (7), Stats., is created to read: CSB 2.012 Note(L) methcathinone, including its salts and salts of isomers.
CSB 2.012 Note(24) Subdivision 4m of s. 161.16 (2) (a), Stats., is created to read: CSB 2.012 Note4m. Dihydrocodeine;
CSB 2.012 Note(25) Paragraph (d) of s. 161.16 (3), Stats., is repealed.
CSB 2.012 Note(26) Paragraph (am) of s. 161.16 (7), Stats., is created to read: CSB 2.012 Note(am) Glutethimide;
